3.48
+0.365(+11.74%)
Currency In USD
Previous Close | 3.11 |
Open | 3.25 |
Day High | 3.63 |
Day Low | 3.13 |
52-Week High | 4.49 |
52-Week Low | 0.25 |
Volume | 455,034 |
Average Volume | 622,055 |
Market Cap | 44.69M |
PE | -5.35 |
EPS | -0.65 |
Moving Average 50 Days | 3.32 |
Moving Average 200 Days | 1.85 |
Change | 0.37 |
If you invested $1000 in Nexalin Technology, Inc. (NXL) since IPO date, it would be worth $1,544.44 as of February 05, 2025 at a share price of $3.475. Whereas If you bought $1000 worth of Nexalin Technology, Inc. (NXL) shares 2 years ago, it would be worth $3,278.3 as of February 05, 2025 at a share price of $3.475.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Nexalin’s Breakthrough DIFS™ Neurostimulation Device Demonstrates Reduction in Blood Pressure while Enhancing Mental Health According to New Landmark Study
GlobeNewswire Inc.
Feb 03, 2025 1:30 PM GMT
HOUSTON, TX, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, announces the publication of a landmark study in t
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session, Today, January 23
GlobeNewswire Inc.
Jan 23, 2025 4:00 PM GMT
HOUSTON, TX, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) is pleased to invite investors to a webinar today, January 23, 2025, at 4:15 p.m. ET. The exclusive event, hosted by RedChip C
Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025
GlobeNewswire Inc.
Jan 14, 2025 1:30 PM GMT
DIFS Technology: A Potential Game-Changer for Mental Health Treatments Setting New Benchmarks: 65% Response Rate Shown in Completed Depression Trials Alzheimer’s Research Shows Promising Results with Increased Brain Activity Virtual Clinic Poised to